View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthca...

Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Wednesday, February 25, 2026, at 2:00 p.m. ET. A live webcast of the presentation can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at axsom...

 PRESS RELEASE

Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation w...

Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement agreement with Alkem Laboratories Ltd. (Alkem) resolving patent litigation related to Axsome’s product SUNOSI® (solriamfetol). The litigation, which is pending in the United States District Court for the District of New Jersey, resulted from...

Principal Financial Group Inc: 1 director

A director at Principal Financial Group Inc sold 7,340 shares at 95.000USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

 PRESS RELEASE

Ryman Hospitality Properties, Inc. Successfully Completes Refinancing ...

Ryman Hospitality Properties, Inc. Successfully Completes Refinancing of $700 Million Revolving Credit Facility and Increases Size to $850 Million NASHVILLE, Tenn., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP), a leading lodging and hospitality real estate investment trust (“REIT”) that specializes in upscale convention center resorts and leading entertainment experiences, today successfully refinanced its revolving credit facility, increasing the size from $700 million to $850 million and extending the maturity from May 2027 to January 2030. The amende...

 PRESS RELEASE

Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financ...

Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23 NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the fourth quarter and full year 2025 on Monday, February 23, 2026, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update...

 PRESS RELEASE

Ryman Hospitality Properties, Inc. Announces 2025 Tax Classification o...

Ryman Hospitality Properties, Inc. Announces 2025 Tax Classification of Shareholder Dividend Distributions NASHVILLE, Tenn., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and country music entertainment experiences, today announced the 2025 tax classification of the dividend distributions made to the Company’s shareholders. The income tax classification as expected to be reported on Form 1099-DIV is as fol...

 PRESS RELEASE

Ryman Hospitality Properties, Inc. Announces Participation in Upcoming...

Ryman Hospitality Properties, Inc. Announces Participation in Upcoming Institutional Investor Conferences NASHVILLE, Tenn., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (“RHP”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and country music entertainment experiences, announced today its participation in two upcoming institutional investor conferences. Mark Fioravanti, President and Chief Executive Officer, and Jennifer Hutcheson, Executive Vice President and Chief Fi...

 PRESS RELEASE

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the ...

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced the first patient has been dosed in the FORWARD Phase 3 trial of AXS-14 (esreboxetine) for the management of fibromyalgia. FORWARD (Fibromyalgia Response with Esreboxetine Evaluated Using a Randomized Withdrawal Research Design) is a Phase 3, double-blind, placebo-controlled, multicenter,...

 PRESS RELEASE

SuRo Capital Corp. Fourth Quarter and Fiscal Year 2025 Investment Por...

SuRo Capital Corp. Fourth Quarter and Fiscal Year 2025 Investment Portfolio Update Generated Meaningful Portfolio Liquidity and Distributed Capital During 2025 Committed $20.0 Million to TensorWave Investment Expanding Exposure to AI Infrastructure NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ) today provided the following update on its investment portfolio for the fourth quarter and fiscal year ended December 31, 2025. “2025 was a strong year for SuRo Capital. Our performance was driven by growing recognition of the valu...

 PRESS RELEASE

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year ...

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue Total preliminary 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively, representing 65% and 66% annual growth, respectively  AUVELITY® preliminary 4Q and full year 2025 net product sales of $155.1 million and $507.1 million, respectively SUNOSI® preliminary 4Q and full year 2025 net product revenue of $36.7 million and $124.8 million, respectively SYMBRAVO® preliminary 4Q and full year 2025 net product sales of $4.1 million and $6.6 million, respectively...

 PRESS RELEASE

Axsome Therapeutics Announces FDA Acceptance and Priority Review of Su...

Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s supplemental New Drug Application (NDA)...

 PRESS RELEASE

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 i...

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has received formal pre-New Drug Application (NDA) meeting minutes from the U.S. Food and Drug Administration (FDA) supporting an NDA submission for AXS-12 in narcolepsy. AXS-12 (reboxetine) is a highly se...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 23, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 18, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Ryman Hospitality Properties, Inc. Announces Fourth Quarter 2025 Earni...

Ryman Hospitality Properties, Inc. Announces Fourth Quarter 2025 Earnings Conference Call – Tuesday, February 24, 2026, 10 a.m. ET NASHVILLE, Tenn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences, announced today that it will release its fourth quarter 2025 earnings results after the market closes on Monday, February 23, 2026. Management will hold a conference call to discuss the quarter’s resu...

 PRESS RELEASE

Ryman Hospitality Properties, Inc. Declares Fourth Quarter Dividend

Ryman Hospitality Properties, Inc. Declares Fourth Quarter Dividend NASHVILLE, Tenn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences, today announced that the Board of Directors has authorized, and the Company has declared a fourth quarter cash dividend of $1.20 per share of common stock, to be paid on January 15, 2026, to stockholders of record as of December 31, 2025. About Ryman Hospitality...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch